Recent evidence demonstrates that PCSK9 also enhances the synthesis and secretion of triglyceride-rich lipoproteins13, another important risk factor for cardiovascular disease, which is associated with NAFLD development14. This evidence concerns the gene PCSK9 and metabolic dysfunction-associated steatotic liver disease.